Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high risk for infection, according to an interim analysis of the phase 3 PURPOSE ...
Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test (TST ...
DENVER -- Five cases of HIV infection associated with cosmetic platelet-rich plasma (PRP) microneedling, known as a "vampire facial," were linked to one spa in New Mexico, according to a report from ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Three women were diagnosed with HIV after ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...
If you have HIV, you may know that you’re at higher risk for other health conditions, such as heart, kidney, and liver disease. But did you know you could be more likely to develop psoriasis, too?
Prevention—what doesn’t work? In a session entitled “Status of the U.S. HIV/AIDS Epidemic: Is It Changing and If Not, Why Not?” Harold Jaffe, MD, former head of the CDC, discussed a not-yet-published ...
Zacks Investment Research on MSN
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...
If PIFELTRO is coadministered with rifabutin, increase PIFELTRO dosage to one tablet twice daily (approximately 12 hours apart). Consult the full Prescribing Information prior to and during treatment ...
Mpox, formerly known as monkeypox, can produce a more severe and more deadly form of disease in people living with advanced HIV infections, researchers wrote in the Lancet medical journal on Tuesday, ...
Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time. Antiretrovirals are the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results